INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 131 filers reported holding INSMED INC in Q3 2018. The put-call ratio across all filers is 2.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $117,508,000 | +26.8% | 4,653,772 | +6.0% | 0.15% | +39.6% |
| Q2 2023 | $92,652,000 | +34.1% | 4,391,080 | +8.4% | 0.11% | +29.3% |
| Q1 2023 | $69,093,000 | -5.3% | 4,052,364 | +11.0% | 0.08% | -4.7% |
| Q4 2022 | $72,943,000 | -4.9% | 3,650,805 | +2.6% | 0.09% | -8.5% |
| Q3 2022 | $76,665,000 | +11.1% | 3,557,924 | +1.7% | 0.09% | +22.1% |
| Q2 2022 | $69,000,000 | -13.0% | 3,499,010 | +3.7% | 0.08% | +28.3% |
| Q1 2022 | $79,315,000 | -8.4% | 3,375,105 | +6.1% | 0.06% | -16.7% |
| Q4 2021 | $86,620,000 | -6.8% | 3,179,883 | -5.8% | 0.07% | -8.9% |
| Q3 2021 | $92,954,000 | +2.4% | 3,375,266 | +5.8% | 0.08% | +5.3% |
| Q2 2021 | $90,777,000 | +914.9% | 3,189,635 | +1114.6% | 0.08% | +476.9% |
| Q1 2021 | $8,944,000 | +5745.8% | 262,617 | +5625.2% | 0.01% | – |
| Q4 2020 | $153,000 | +4.1% | 4,587 | 0.0% | 0.00% | – |
| Q3 2020 | $147,000 | +16.7% | 4,587 | 0.0% | 0.00% | – |
| Q2 2020 | $126,000 | -92.4% | 4,587 | -93.4% | 0.00% | -100.0% |
| Q2 2018 | $1,656,000 | – | 70,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,056,797 | $33,965,000 | 14.39% |
| Palo Alto Investors LP | 6,032,956 | $193,899,000 | 10.64% |
| Sycale Advisors (NY) LLC | 360,829 | $11,597,000 | 9.99% |
| Burrage Capital Management LLC | 165,400 | $5,316,000 | 4.20% |
| First Light Asset Management, LLC | 1,025,341 | $32,954,000 | 3.38% |
| Rubric Capital Management LP | 1,100,000 | $35,354,000 | 3.30% |
| Sofinnova Investments, Inc. | 615,143 | $19,771,000 | 1.47% |
| Endurant Capital Management LP | 144,313 | $4,638,000 | 1.37% |
| Parkwood LLC | 70,235 | $5,514,000 | 0.85% |
| Novo Holdings A/S | 430,107 | $13,824,000 | 0.69% |